cgt9486
cogent biosciences
['apex']
daniel deangelo, md, phd, shares results of a phase 2 study of a novel kit inhibitor for advanced systemic mastocytosis. today at 4:45pm #ash22 
Your official source for @DanaFarber Cancer Institute news | Research, science, and innovation | Media requests: media@dfci.harvard.edu or 617-632-4090